All Stories

  1. Career building in countries with electrophysiology underdevelopment: roadblocks and solutions—an EHRA Young EP Report
  2. OUP accepted manuscript
  3. Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities
  4. Wearable cardioverter-defibrillator and ventricular arrhythmias: risk stratification in patients with shorter device use—Authors’ reply
  5. Predictors of long-term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block
  6. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry)
  7. Effectiveness of high rate and delayed detection ICD programming by race: A MADIT-RIT substudy
  8. Baseline adverse electrical remodeling and the risk for ventricular arrhythmia in Cardiac Resynchronization Therapy Recipients (MADIT CRT)
  9. Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT-RIT substudy
  10. Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy
  11. Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission
  12. Left ventricular assist devices in patients with renal dysfunction: where are we heading?
  13. European Heart Rhythm Association Young Electrophysiology Community: introducing our National Ambassadors of Italy, Turkey, and Poland
  14. Effect of Significant Weight Change on Inappropriate Implantable Cardioverter-Defibrillator Therapy
  15. European Heart Rhythm Association Young Electrophysiology Community: the future is just ahead
  16. Long-QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder
  17. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT)
  18. Gender Differences in the Risk of Neurological Events and Subsequent Outcome in Left Ventricular Assist Device Patients
  19. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis
  20. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study
  21. LEFT VENTRICULAR LEAD LOCATION IMPACTS LONG-TERM CLINICAL OUTCOME IN LEFT BUNDLE BRANCH BLOCK PATIENTS
  22. LONG-TERM OUTCOME WITH CARDIAC-RESYNCHRONIZATION THERAPY IN UNITED STATES AND EUROPEAN PATIENTS: MADIT-CRT
  23. The Burden and Morphology of Premature Ventricular Contractions and their Impact on Clinical Outcomes in Patients Receiving Biventricular Pacing in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)
  24. The Effect of ICD Programming on Inappropriate and Appropriate ICD Therapies in Ischemic and Nonischemic Cardiomyopathy: The MADIT-RIT Trial
  25. Circadian Distribution of Ventricular Tachyarrhythmias and Association with Mortality in the MADIT-CRT Trial
  26. Club 35 Poster session 3: Friday 5 December 2014, 08:30-18:00 * Location: Poster area
  27. Response to Letter Regarding, "PR Interval Identifies Clinical Response in Patients With Non-Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Sub-Study" by Kutyifa et al
  28. Letter by Jackson et al Regarding, "PR Interval Identifies Clinical Response in Patients With Non-Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Substudy" by Kutyifa et al
  29. Comparison of Age (<75 Years Versus ≥75 Years) to Risk of Ventricular Tachyarrhythmias and Implantable Cardioverter Defibrillator Shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)
  30. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high‐volume, single‐centre experience
  31. Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results From the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Ther...
  32. Response to Letter Regarding Article, "Syncope in High-Risk Cardiomyopathy Patients With Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association With Mortality: Results From the Multicenter Automatic Defibrillator Implantation ...
  33. Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)
  34. Association Between Frequency of Atrial and Ventricular Ectopic Beats and Biventricular Pacing Percentage and Outcomes in Patients With Cardiac Resynchronization Therapy
  35. Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)
  36. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling
  37. The Impact of Nonsustained Ventricular Tachycardia on Reverse Remodeling, Heart Failure, and Treated Ventricular Tachyarrhythmias in MADIT-CRT
  38. PR Interval Identifies Clinical Response in Patients With Non-Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Substudy
  39. Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT
  40. ICD Programming to Reduce Shocks and Improve Outcomes
  41. Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: A MADIT-CRT substudy
  42. Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure
  43. Predictors of Spontaneous Reverse Remodeling in Mild Heart Failure Patients With Left Ventricular DysfunctionCLINICAL PERSPECTIVE
  44. A Metric for Evaluating the Cardiac Response to Resynchronization Therapy
  45. CARDIAC RESYNCHRONIZATION THERAPY IS ASSOCIATED WITH REDUCTIONS IN LEFT ATRIAL VOLUME AND INAPPROPRIATE ICD THERAPY IN MADIT-CRT
  46. The Effect of Intermittent Atrial Tachyarrhythmia on Heart Failure or Death in Cardiac Resynchronization Therapy With Defibrillator Versus Implantable Cardioverter-Defibrillator Patients
  47. The Effect of Weight Loss on Clinical Outcomes in Patients Implanted With a Cardiac Resynchronization Therapy Device—A MADIT-CRT Substudy
  48. O152 Intraoperative right to left ventricular interlead delay predicts outcome in de novo CRT recipients
  49. Risk Factors and Outcomes Associated With the Development of Myocardial Ischemic Events in Patients Who Receive Cardiac Resynchronization Therapy
  50. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D
  51. Syncope in High-Risk Cardiomyopathy Patients With Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association With Mortality: Results From the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MAD...
  52. Impact of Carvedilol and Metoprolol on Inappropriate Implantable Cardioverter-Defibrillator Therapy
  53. Ambulatory ECG Monitoring in Atrial Fibrillation Management
  54. Benefit of cardiac resynchronization therapy in patients without a history of advanced heart failure symptoms enrolled in MADIT-CRT
  55. Intraoperative right to left ventricular interlead delay predicts outcome in CRT recipients
  56. Appropriate ICD therapy for slow-rate VT predicts increased risk of appropriate therapy for high-rate VT/VF in the MADIT-RIT trial
  57. Risk factors and clinical implications of the development of ischemic events in patients who receive cardiac resynchronization therapy
  58. Right ventricular deformation is determined by right ventricluar dimensions in elite athletes - a 2D speckle tracking echocardiography study
  59. Influence of prior atrial arrhythmias on the effects of innovative programming in reducing inappropriate therapy and death in MADIT-RIT
  60. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT
  61. Effect on Cardiac Function of Cardiac Resynchronization Therapy in Patients With Right Bundle Branch Block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] Trial)
  62. Direct comparison of steroid and non-steroid eluting small surface pacing leads: Randomized, multicenter clinical trial
  63. Clinical Impact, Safety, and Efficacy of Single- versus Dual-Coil ICD Leads in MADIT-CRT
  64. Influence of Diabetes Mellitus on Inappropriate and Appropriate Implantable Cardioverter-Defibrillator Therapy and Mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial
  65. Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D
  66. Poster session 3
  67. Oral Abstract Session: Outcomes in CRT
  68. Improving implantable cardioverter defibrillator therapy through better programming
  69. Dyssynchrony and the Risk of Ventricular Arrhythmias
  70. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT
  71. EFFICACY OF DIFFERENT β-BLOCKERS IN LONG QT-SYNDROME
  72. INFLUENCE OF DIFFERENT BETA-BLOCKERS ON INAPPROPRIATE THERAPY IN THE MADIT-CRT TRIAL
  73. LONG TERM MORTALITY IN LOW RISK ADULT PATIENTS WITH CONGENITAL LONG QT SYNDROME: LIFE INSURANCE CONSIDERATIONS
  74. THE EFFECT OF ATRIAL TACHYARRHYTHMIA ON HEART FAILURE OR DEATH IN CRT-D VERSUS ICD PATIENTS: A MADIT-CRT SUB STUDY
  75. RISK OF HEART FAILURE HOSPITALIZATION OR DEATH FOLLOWING NON-CARDIOVASCULAR HOSPITALIZATION IN PATIENTS WITH MILDLY SYMPTOMATIC HEART FAILURE TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY
  76. PREDICTORS OF DYSSYNCHRONY IMPROVEMENT AND ITS ROLE IN SUBSEQUENT OUTCOME IN CRT-D PATIENTS: RESULTS FROM THE LONG-TERM FOLLOW-UP OF MADIT-CRT
  77. THE EFFECT OF WEIGHT LOSS ON THE INCIDENCE OF HEART FAILURE OR DEATH IN MADIT-CRT PATIENTS
  78. NOVEL PARAMETER OF ELECTRICAL ACTIVATION BETTER PREDICTS RESPONSE TO CRT-D IN MALES THAN BASELINE QRS DURATION: A MADIT-CRT SUB-STUDY
  79. The Influence of Left Ventricular Ejection Fraction on the Effectiveness of Cardiac Resynchronization Therapy
  80. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial
  81. Monday, 27 August 2012
  82. Tuesday, 28 August 2012
  83. Evaluación del paciente que no responde al tratamiento de resincronización cardiaca: un enfoque escalonado completo
  84. How to Assess the Nonresponder to Cardiac Resynchronization Therapy–A Comprehensive Stepwise Approach
  85. THE IMPACT OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH RANGE OF LEFT VENTRICULAR EJECTION FRACTIONS IN MADIT-CRT
  86. Usefulness of electroanatomical mapping during transseptal endocardial left ventricular lead implantation
  87. Poster Session 5: Saturday 10 December 2011, 08:30-12:30 * Location: Poster Area
  88. Poster Session 4: Friday 9 December 2011, 14:00-18:00 * Location: Poster Area
  89. Real-time three-dimensional transesophageal echocardiography-guided atrial fibrillation ablation procedure
  90. LEFT VENTRICULAR LEAD POSITION AND THE RISK OF VENTRICULAR ARRHYTHMIAS IN THE MADIT-CRT STUDY
  91. DYSSYNCHRONY AND THE RISK OF VENTRICULAR ARRHYTHMIAS IN THE MADIT-CRT TRIAL
  92. UNSUCCESSFUL ATTEMPT TO TERMINATE VT BY ATP PREDICTS POOR CLINICAL OUTCOME IN MADIT CRT TRIAL
  93. The role of cardiovascular magnetic resonance imaging in cardiac resynchronisation therapy
  94. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008
  95. Successful management and long term outcome of an accidental subclavian artery injury with a 9 french dilator during pacemaker implantation with collagen-based closure device
  96. Minimal invasive coronary sinus lead reposition technique for the treatment of phrenic nerve stimulation
  97. Intracardiac echocardiography guided cardiac tumormass biopsy
  98. Successful cardiac resynchronization therapy after heart transplantation
  99. The additional prognostic power of diabetes mellitus on coronary flow reserve in patients with suspected coronary artery disease
  100. Stabilization of the Coronary Sinus Electrode Position with Coronary Stent Implantation to Prevent and Treat Dislocation
  101. Szívelégtelenség reszinkronizációs kezeléser
  102. Early results of comprehensive cardiac rehabilitation after biventicular pacemaker implantation